REVIEW ARTICLE
Year : 2013  |  Volume : 4  |  Issue : 5  |  Page : 20-28

Pharmacovigilance in Italy: An overview


1 Department of Science of Health, School of Medicine, University of Catanzaro, and Pharmacovigilance's Centre Calabria Region, University Hospital Mater Domini, Catanzaro, Italy
2 Pharmacy Unit, Mater Domini Hospital, Catanzaro, Italy
3 Regional Centre of Pharmacovigilance and Pharmacoepidemiology, and Department of Experimental Medicine "L. Donatelli", Second University of Naples, Naples, Italy

Correspondence Address:
Emilio Russo
Chair of Pharmacology; Department of Science of Health, School of Medicine, University of Catanzaro, Via T. Campanella, 115; 88100 Catanzaro
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.120942

Rights and Permissions

Introduction: Spontaneous reporting of adverse drug reactions (ADRs) is the basis of pharmacovigilance. In fact, ADRs are associated with a high degree of morbidity and mortality. However, underreporting by all healthcare professionals remains the major problem in Italy and in the rest of the world. The dissemination of pharmacovigilance knowledge among Italian healthcare professionals, and the new pharmacovigilance regulations may promote the early detection and reporting of ADRs. This review examines the legislative framework concerning the pharmacovigilance in Italy. Materials and Methods: The information was collected from scientific articles and the websites of the Italian Ministry of Health and the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA). Results: The pharmacovigilance system, both in Italy and Europe, has undergone profound changes. European legislation on pharmacovigilance has been changed in 2010 according to the EU Regulation 1235/2010 and Directive 2010/84/EU. Basically, the changes tend to increase the efficiency, speed and transparency of pharmacovigilance activities. The new Regulation (1235/2010) and the Directive (2010/84/EU) aim to strengthen the system of pharmacovigilance, establish more precisely who is obliged to do what, and allow faster and easier circulation and retrieval of information about ADRs. Conclusion: A greater knowledge on what is the Italian pharmacovigilance legislation will be useful to improve the status of ADRs reporting and spread the culture of spontaneous reporting.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3090    
    Printed60    
    Emailed2    
    PDF Downloaded713    
    Comments [Add]    
    Cited by others 18    

Recommend this journal